2ycs: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2ycs.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_2ycs", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_2ycs| PDB=2ycs | SCENE= }} | |||
===CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV788=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_21963792}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 21963792 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_21963792}} | |||
==About this Structure== | |||
[[2ycs]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2YCS OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:021963792</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | |||
[[Category: Non-specific serine/threonine protein kinase]] | |||
[[Category: Jobson, A G.]] | |||
[[Category: Lountos, G T.]] | |||
[[Category: Pommier, Y.]] | |||
[[Category: Self, C R.]] | |||
[[Category: Shoemaker, R H.]] | |||
[[Category: Tropea, J E.]] | |||
[[Category: Waugh, D S.]] | |||
[[Category: Zhang, G.]] | |||
[[Category: Anticancer drug design]] | |||
[[Category: Transferase]] |
Revision as of 15:17, 16 November 2011
CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV788CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV788
Template:ABSTRACT PUBMED 21963792
About this StructureAbout this Structure
2ycs is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Lountos GT, Jobson AG, Tropea JE, Self CR, Zhang G, Pommier Y, Shoemaker RH, Waugh DS. Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy. J Struct Biol. 2011 Dec;176(3):292-301. Epub 2011 Sep 22. PMID:21963792 doi:10.1016/j.jsb.2011.09.008